Comparison of Long-Term (4-Year) Outcomes of Patients With Unprotected Left Main Coronary Artery Narrowing Treated With Drug-Eluting Stents Versus Coronary-Artery Bypass Grafting

American Journal of Cardiology

Volumn 105, Issue 12, 2010, Pages 1728-1734

  Wu, XiaoFan ^a   Chen, YunDai ^c   Liu, Hong ^a   Teirstein, Paul S ^d   Kirtane, Ajay J ^a   Ge, ChangJiang ^a   Song, XianTao ^a   Chen, Xin ^a   Gu, ChengXiong ^b   Huang, FangJiong ^b   Lv, ShuZheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SCRIPPS CLINIC   (United States)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; CYPHER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDEAVOR; EXCEL; FIREBIRD; PARTNER; RAPAMYCIN; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LEFT CORONARY ARTERY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STENT THROMBOSIS;

AGED; AGED, 80 AND OVER; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DEATH, SUDDEN, CARDIAC; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953143934     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.353     Document Type: Article

References (27)

1. Mehilli J., Kastrati A., Byrne R.A., Bruskina O., Lijima R., Schulz S., Pache J., Seyfarth M., Massberg S., Laugwitz K.L., Dirschinger J., Schomig A., and ISAR-LEFT-MAIN (Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions) Study Investigators. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 53 (2009) 1760-1768
2. Lee M.S., Kapoor N., Jamal F., Czer L., Aragon J., Forrester J., Kar S., Dohad S., Kass R., Eigler N., Trento A., Shah P.K., and Makkar R.R. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary disease. J Am Coll Cardiol 47 (2006) 864-870
3. Chieffo A., Morici N., Maisano F., Bonizzoni E., Cosgrave J., Montorfano M., Airoldi F., Carlino M., Michev I., Melzi G., Sangiorgi G., Alfieri O., and Colombo A. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 113 (2006) 2542-2547
4. Palmerini T., Marzocchi A., Marrozzini C., Ortolani P., Saia F., Savini C., Bacchi-Reggiani L., Gianstefani S., Virzi S., Manara F., Kiros Weldeab M., Marinelli G., Di Bartolomeo R., and Branzi A. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna registry). Am J Cardiol 98 (2006) 54-59
5. Seung K.B., Park D.W., Kim Y.H., Lee S.W., Lee C.W., Hong M.K., Park S.W., Yun S.C., Gwon H.C., Jeong M.H., Jang Y., Kim H.S., Kim P.J., Seong I.W., Park H.S., Ahn T., Chae I.H., Tahk S.J., Chung W.S., and Park S.J. Stents versus coronary artery bypass grafting for left main coronary artery disease. N Engl J Med 358 (2008) 1781-1792
6. Biondi-Zoccai G.G., Lotrionte M., Moretti C., Meliga E., Agostoni P., Valginigli M., Migliorini A., Antoniucci D., Carrie D., Sangiorgi G., Chieffo A., Colombo A., Price M.J., Teirstein P.S., Christiansen E.H., Abbate A., Testa L., Gunn J.P., Burzotta F., Laudito-Trevi G.P., and Sheiban I. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J 155 (2007) 274-283
7. Chieffo A., Park S.J., Valgimigli M., Kim Y.H., Daemen J., Sheiban I., Truffa A., Montorfano M., Airoldi F., Sangiorgi G., Carlino M., Mechev I., Lee C.W., Hong M.K., Park S.W., Moretti C., Bonizzoni E., Rogacha R., Serruys P.W., and Colombo A. Favorable long-term outcomes after drug-eluting stent implantation in non-bifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation 116 (2007) 158-163
8. Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., Stahle E., Feldman T.E., van den Brand M., Bass E.J., Van Dyck N., Leadley K., Dawkins K.D., Mohr F.W., and SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
9. Buszman P.E., Kiesz S.R., Bochenek A., Peszek-Przybyla E., Szkrobka I., Debinski M., Bialkowska B., Dudek D., Gruszka A., Zurakowski A., Milewski K., Wilczynski M., Rzeszutko L., Buszman P., Szymszal J., Martin J.L., and Tendera M. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 51 (2008) 538-545
10. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European System for Cardiac Operative Risk Evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
11. Parsonnet V., Dean D., and Bernstein A.D. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79 suppl (1989) I-3-I-12
12. Colombo A., Orlic D., Stankovic G., Corvaja N., Spanos V., Montorfano M., Liistro F., Carlino M., Airoldi F., Chieffo A., and Di Mario C. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 107 (2003) 2178-2180
13. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz T.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
14. Park S.J., Lee C.W., Kim Y.H., Lee J.H., Hong M.K., Kim J.J., and Park S.W. Technical feasibility, safety, and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing. Am J Cardiol 90 (2002) 374-378
15. Colombo A., Stankovic G., Orlic D., Corvaja N., Liistro F., Airoldi F., Chieffo A., Spanos V., Montorfano M., and Di Mario C. Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Catheter Cardiovasc Interv 60 (2003) 145-151
16. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W., and Academic Research Consortium. Clinical end points in coronary stent trials. A case for standardized definitions. Circulation 115 (2007) 2344-2351
17. Rodes-Cabau J., DeBlois J., Betrand O.F., Mohammadi S., Courtis J., Larose E., Dagenais F., Dery J.P., Mathieu P., Rousseau M., Barbeau G., Baillot R., Gleeton O., Perron J., Nguyen C.M., Roy L., Doyle D., De Larochelliere R., Bogaty P., and Voisine P. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation 118 (2008) 2374-2381
18. Makikallio T.H., Niemela M., Kervinen K., Jokinen V., Laukkanen J., Ylitalo I., Tulppo M.P., Juvonen J., and Huikuri H.V. Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting. Ann Med 40 (2008) 437-443
19. Cheng C.I., Lee F.Y., Chang J.P., Hsueh S.K., Hsieh Y.K., Fang C.Y., Chen S.M., Yang C.H., Yip H.K., Chen M.C., Fu M., and Wu C.J. Long-term outcomes of intervention for unprotected left main coronary artery stenosis: coronary stenting vs coronary artery bypass grafting. Circ J 73 (2009) 705-712
20. Chieffo A., Stankovic G., Bonizzoni E., Tsagalou E., Iakovou I., Montorfano M., Airoldi F., Michev I., Sangiorgi M.G., Carlino M., Vitrella G., and Colombo A. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111 (2005) 791-795
21. Park S.J., Kim Y.H., Lee B.K., Lee S.W., Lee S.W., Hong M.K., Kim J.J., Mintz G.S., and Park S.W. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45 (2005) 351-356
22. Colombo A., Moses J.W., Morice M.C., Ludwig J., Holmes Jr. D.R., Spanos V., Louvard Y., Desmedt B., Di Mario C., and Leon M.B. Randomized study to evaluate sirolimus eluting stents implanted at coronary bifurcation lesions. Circulation 109 (2004) 1244-1249
23. Meliga E., Garcia-Garcia H.M., Valgimigli M., Chieffo A., Biondi-Zoccai G., Maree A.O., Cook S., Reardon L., Moretti C., De Servi S., Palacios I.F., Windecker S., Colombo A., van Domburg R., Sheiban I., and Serruys P.W. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease. The DELFT (Drug Eluting Stent for Left Main) registry. J Am Coll Cardiol 51 (2008) 2212-2219
24. Khot U.N., Friedman D.T., Pettersson G., Smedira N.G., Li J., and Ellis S.G. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation 109 (2004) 2086-2091
25. Alexander J.H., Hafley G., Harrington R.A., Peterson E.D., Ferguson Jr. T.B., Lorenz T.J., Goyal A., Gibson M., Mack M.J., Gennevois D., Califf R.M., Kouchoukos N.T., and PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 294 (2005) 2446-2454
26. Min P.K., Jung J.H., Ko Y.G., Choi D., Jang Y., and Shim W.H. Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantitative coronary angiography and volumetric intravascular ultrasound study. Circ J 71 (2007) 1685-1690
27. Lee S.W., Park S.W., Kim Y.H., Yun S.C., Park D.W., Lee C.W., Hong M.K., Kim H.S., Ko J.K., Park J.H., Lee J.H., Choi S.W., Seong I.W., Cho Y.H., Lee N.H., Kim J.H., Chun K.J., and Park S.J. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients). J Am Coll Cardiol 51 (2008) 1181-1187